well, that is what EXAS is trying to point out, but the imperial offices of the FDA may have something a little different to say. The fact that FDA hasn't pulled PG+ off market in the last few years makes it very probable that any FDA requirements/needs will continue to be easy enough to fulfill. But, much like past performance is no guarantee of future results for investments, the fact that the FDA has required nothing more than a little explanation doesn't mean some bearocrat doesn't get something up his (or her) butt and cause some grief short run.
LOL. Now that this news is out of the way, we should see some great buying opportunities over the next several months. If this news was the only thing holding it around 2, we could see the 1.60's again.
look man, I'd like a few more shares too, butt why you quibbling about a few pennies. Hopefully you had enough sense to buy a couple weeks ago. BTW, are you up to a full 1% of the company yet. We're close.